Increasing evidence suggests that HMGB2 is involved in various malignancies like prostate cancer, cervical cancer, lung cancer, melanoma, pancreatic ductal adenocarcinoma (PDAC), and GC. This evidence concerns the gene HMGB2 and prostate carcinoma.